US Patent Issued to Roche Diagnostics Operations on May 12 for "S100A8 as blood biomarker for the non-invasive diagnosis of Endometriosis" (Swiss Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,625,146, issued on May 12, was assigned to Roche Diagnostics Operations Inc. (Indianapolis).

"S100A8 as blood biomarker for the non-invasive diagnosis of Endometriosis" was invented by Aikaterini Georgopoulou (Lucerne, Switzerland) and Martin Hund (Horw, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods of assessing whether a patient has endometriosis or is at risk of developing endometriosis, to methods of selecting a patient for therapy, and method of monitoring a patient suffering from endometriosis or being treated for endometriosis by determining the amount or concentration of S100A8 in a sample of t...